Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients

C. Zoccali, F. Mallamaci, F. A. Benedetto, G. Tripepi, S. Parlongo, A. Cataliotti, S. Cutrupi, G. Giacone, I. Bellanuova, E. Cottini, L. S. Malatino

Research output: Contribution to journalArticle

267 Citations (Scopus)

Abstract

This study was designed to investigate the relationship among brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) and left ventricular mass (LVM), ejection fraction, and LV geometry in a large cohort of dialysis patients without heart failure (n = 246) and to test the prediction power of these peptides for total and cardiovascular mortality. In separate multivariate models of LVM, BNP and ANP were the strongest independent correlates of the LVM index. In these models, the predictive power of BNP was slightly stronger than that of ANP. Both natriuretic peptides also were the strongest independent predictors of ejection fraction, and again BNP was a slightly better predictor of ejection fraction than ANP. In separate multivariate Cox models, the relative risk of death was significantly higher in patients of the third tertile of the distribution of BNP and ANP than in those of the first tertile (BNP, 7.14 [95% confidence interval (CI), 2.83 to 18.01, P = 0,00001]; ANP, 4.22 [95% CI, 1.79 to 9.92, P = 0.001]), and a similar difference was found for cardiovascular death (BNP, 6.72 [95% CI, 2.44 to 18.54, P = 0.0002]; ANP, 3.80 [95% CI, 1.44 to 10.03, P = 0.007]). BNP but not ANP remained as an independent predictor of death in a Cox's model including LVM and ejection fraction. Cardiac natriuretic peptides are linked independently to LVM and function in dialysis patients and predict overall and cardiovascular mortality. The measurement of the plasma concentration of BNP and ANP may be useful for risk stratification in these patients.

Original languageEnglish (US)
Pages (from-to)1508-1515
Number of pages8
JournalJournal of the American Society of Nephrology
Volume12
Issue number7
StatePublished - 2001
Externally publishedYes

Fingerprint

Natriuretic Peptides
Brain Natriuretic Peptide
Atrial Natriuretic Factor
Left Ventricular Function
Dialysis
Mortality
Confidence Intervals
Proportional Hazards Models
Stroke Volume
Heart Failure
Peptides

ASJC Scopus subject areas

  • Nephrology

Cite this

Zoccali, C., Mallamaci, F., Benedetto, F. A., Tripepi, G., Parlongo, S., Cataliotti, A., ... Malatino, L. S. (2001). Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. Journal of the American Society of Nephrology, 12(7), 1508-1515.

Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. / Zoccali, C.; Mallamaci, F.; Benedetto, F. A.; Tripepi, G.; Parlongo, S.; Cataliotti, A.; Cutrupi, S.; Giacone, G.; Bellanuova, I.; Cottini, E.; Malatino, L. S.

In: Journal of the American Society of Nephrology, Vol. 12, No. 7, 2001, p. 1508-1515.

Research output: Contribution to journalArticle

Zoccali, C, Mallamaci, F, Benedetto, FA, Tripepi, G, Parlongo, S, Cataliotti, A, Cutrupi, S, Giacone, G, Bellanuova, I, Cottini, E & Malatino, LS 2001, 'Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients', Journal of the American Society of Nephrology, vol. 12, no. 7, pp. 1508-1515.
Zoccali, C. ; Mallamaci, F. ; Benedetto, F. A. ; Tripepi, G. ; Parlongo, S. ; Cataliotti, A. ; Cutrupi, S. ; Giacone, G. ; Bellanuova, I. ; Cottini, E. ; Malatino, L. S. / Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. In: Journal of the American Society of Nephrology. 2001 ; Vol. 12, No. 7. pp. 1508-1515.
@article{0caf27281d5c4fc4b4ca4d61e14bad5b,
title = "Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients",
abstract = "This study was designed to investigate the relationship among brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) and left ventricular mass (LVM), ejection fraction, and LV geometry in a large cohort of dialysis patients without heart failure (n = 246) and to test the prediction power of these peptides for total and cardiovascular mortality. In separate multivariate models of LVM, BNP and ANP were the strongest independent correlates of the LVM index. In these models, the predictive power of BNP was slightly stronger than that of ANP. Both natriuretic peptides also were the strongest independent predictors of ejection fraction, and again BNP was a slightly better predictor of ejection fraction than ANP. In separate multivariate Cox models, the relative risk of death was significantly higher in patients of the third tertile of the distribution of BNP and ANP than in those of the first tertile (BNP, 7.14 [95{\%} confidence interval (CI), 2.83 to 18.01, P = 0,00001]; ANP, 4.22 [95{\%} CI, 1.79 to 9.92, P = 0.001]), and a similar difference was found for cardiovascular death (BNP, 6.72 [95{\%} CI, 2.44 to 18.54, P = 0.0002]; ANP, 3.80 [95{\%} CI, 1.44 to 10.03, P = 0.007]). BNP but not ANP remained as an independent predictor of death in a Cox's model including LVM and ejection fraction. Cardiac natriuretic peptides are linked independently to LVM and function in dialysis patients and predict overall and cardiovascular mortality. The measurement of the plasma concentration of BNP and ANP may be useful for risk stratification in these patients.",
author = "C. Zoccali and F. Mallamaci and Benedetto, {F. A.} and G. Tripepi and S. Parlongo and A. Cataliotti and S. Cutrupi and G. Giacone and I. Bellanuova and E. Cottini and Malatino, {L. S.}",
year = "2001",
language = "English (US)",
volume = "12",
pages = "1508--1515",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "7",

}

TY - JOUR

T1 - Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients

AU - Zoccali, C.

AU - Mallamaci, F.

AU - Benedetto, F. A.

AU - Tripepi, G.

AU - Parlongo, S.

AU - Cataliotti, A.

AU - Cutrupi, S.

AU - Giacone, G.

AU - Bellanuova, I.

AU - Cottini, E.

AU - Malatino, L. S.

PY - 2001

Y1 - 2001

N2 - This study was designed to investigate the relationship among brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) and left ventricular mass (LVM), ejection fraction, and LV geometry in a large cohort of dialysis patients without heart failure (n = 246) and to test the prediction power of these peptides for total and cardiovascular mortality. In separate multivariate models of LVM, BNP and ANP were the strongest independent correlates of the LVM index. In these models, the predictive power of BNP was slightly stronger than that of ANP. Both natriuretic peptides also were the strongest independent predictors of ejection fraction, and again BNP was a slightly better predictor of ejection fraction than ANP. In separate multivariate Cox models, the relative risk of death was significantly higher in patients of the third tertile of the distribution of BNP and ANP than in those of the first tertile (BNP, 7.14 [95% confidence interval (CI), 2.83 to 18.01, P = 0,00001]; ANP, 4.22 [95% CI, 1.79 to 9.92, P = 0.001]), and a similar difference was found for cardiovascular death (BNP, 6.72 [95% CI, 2.44 to 18.54, P = 0.0002]; ANP, 3.80 [95% CI, 1.44 to 10.03, P = 0.007]). BNP but not ANP remained as an independent predictor of death in a Cox's model including LVM and ejection fraction. Cardiac natriuretic peptides are linked independently to LVM and function in dialysis patients and predict overall and cardiovascular mortality. The measurement of the plasma concentration of BNP and ANP may be useful for risk stratification in these patients.

AB - This study was designed to investigate the relationship among brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) and left ventricular mass (LVM), ejection fraction, and LV geometry in a large cohort of dialysis patients without heart failure (n = 246) and to test the prediction power of these peptides for total and cardiovascular mortality. In separate multivariate models of LVM, BNP and ANP were the strongest independent correlates of the LVM index. In these models, the predictive power of BNP was slightly stronger than that of ANP. Both natriuretic peptides also were the strongest independent predictors of ejection fraction, and again BNP was a slightly better predictor of ejection fraction than ANP. In separate multivariate Cox models, the relative risk of death was significantly higher in patients of the third tertile of the distribution of BNP and ANP than in those of the first tertile (BNP, 7.14 [95% confidence interval (CI), 2.83 to 18.01, P = 0,00001]; ANP, 4.22 [95% CI, 1.79 to 9.92, P = 0.001]), and a similar difference was found for cardiovascular death (BNP, 6.72 [95% CI, 2.44 to 18.54, P = 0.0002]; ANP, 3.80 [95% CI, 1.44 to 10.03, P = 0.007]). BNP but not ANP remained as an independent predictor of death in a Cox's model including LVM and ejection fraction. Cardiac natriuretic peptides are linked independently to LVM and function in dialysis patients and predict overall and cardiovascular mortality. The measurement of the plasma concentration of BNP and ANP may be useful for risk stratification in these patients.

UR - http://www.scopus.com/inward/record.url?scp=0034918556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034918556&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 1508

EP - 1515

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 7

ER -